MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.

Journal article

OBJECTIVE: Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate. CONCLUSION: Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.

Authors: Warakaulle, DR; Gleeson, F

• Publication status: Published
• Journal: AJR. American journal of roentgenology
• Volume: 186
• Issue: 2
• Pages: 510-515
• Publication date: 2006-02-01
• DOI: 10.2214/ajr.04.1516
• EISSN: 1546-3141
• ISSN: 0361-803X
• Language: English
• Keywords: Contrast Media; Middle Aged; Treatment Outcome; Female; Tomography, X-Ray Computed; Piperazines; Male; Gastrointestinal Stromal Tumors; Iopamidol; Aged; Image Processing, Computer-Assisted; Pyrimidines; Protein Kinase Inhibitors; Humans; Aged, 80 and over